BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oncology News, Insights, Stories by OncoDaily - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://oncodailynews.com
X-WR-CALDESC:Events for Oncology News, Insights, Stories by OncoDaily
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Lisbon
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:WEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:WET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:WEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:WET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:WEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:WET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20240310T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20241103T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20260308T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20261101T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Helsinki
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Lisbon:20250308T130000
DTEND;TZID=Europe/Lisbon:20250311T123000
DTSTAMP:20260602T164752
CREATED:20250216T125510Z
LAST-MODIFIED:20250607T195026Z
UID:10000140-1741438800-1741696200@oncodailynews.com
SUMMARY:Upper GI: Technical and Clinical challenges for Radiation Oncologists by ESTRO
DESCRIPTION:Upper GI: Technical and Clinical challenges for Radiation Oncologists by ESTRO will be held from 8-10 March\, 2025 at Lisbon\, Portugal. \nThe Upper GI: Technical and Clinical Challenges for Radiation Oncologists course focuses on addressing the evolving role of radiotherapy in the treatment of upper gastrointestinal (GI) tumors\, which are known for their unfavorable prognosis. Despite these challenges\, there is significant potential for improvement through technological innovations and a multidisciplinary approach. \nThe course provides an interactive educational environment where participants can engage in peer reviews at each stage of radiation therapy practice\, including indication\, prescription\, delineation\, planning\, IGRT\, and outcome evaluation. The course incorporates the latest state-of-the-art technologies and knowledge while considering the perspectives of clinicians\, physicists\, and radiation therapy technologists (RTTs). \nSpecialists from various disciplines will guide participants in understanding the clinical\, anatomic\, and pathological aspects of upper GI tumors\, as well as the therapeutic advancements required for optimal radiation oncology practice. By the end of the course\, participants will be equipped to appropriately indicate radiation therapy\, prescribe treatments\, tailor delineation based on tumor location and stage\, optimize dose distribution\, utilize IGRT technologies effectively\, and monitor tumor response and control.
URL:https://oncodailynews.com/event/244316
LOCATION:Jupiter Hotel\, Avenida da Republica\, 46\, Lisbon\, 1050-195\, Portugal
ATTACH;FMTTYPE=image/jpeg:https://oncodailynews.com/pub/uploads/2025/02/GkOE8qhWoAAsva4-e1740307240872.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20250301T000000
DTEND;TZID=America/Halifax:20250305T000000
DTSTAMP:20260602T164752
CREATED:20241208T200313Z
LAST-MODIFIED:20250608T090016Z
UID:10000097-1740787200-1741132800@oncodailynews.com
SUMMARY:The Nordic Radiotherapy Diploma Programme (NORTHDIP) for Clinical Oncologists by ESTRO
DESCRIPTION:The Nordic Radiotherapy Diploma Programme (NORTHDIP) for Clinical Oncologists by ESTRO will be going on for two years from March 2025 to November 2026. \nThe Nordic Radiotherapy Diploma Programme (NORTHDIP) is a two-year advanced education initiative designed for clinical oncologists across the Nordic countries: Denmark\, Iceland\, Finland\, Norway\, and Sweden. The programme addresses the need for supplementary radiotherapy training for oncologists who specialize in radiotherapy after their clinical oncology education. \nThe goal of NORTHDIP is to enhance radiotherapy skills and foster collaboration among Nordic clinical oncologists\, ultimately advancing expertise in the region and promoting collaborative research and development in radiotherapy. \nThe programme’s content is aligned with ESTRO’s core curriculum for radiation oncologists and covers a variety of advanced topics: \n\nSweden 2024: Advanced radiophysics\, dose planning\, organs-at-risk constraints\, and advanced technologies.\nNorway 2025: Radiobiology\, benign diseases\, and palliative care.\nFinland 2025: Reirradiation\, stereotactic radiotherapy\, and BNCT (Boron Neutron Capture Therapy).\nDenmark 2026: Adaptive radiotherapy and imaging (CBCT\, dual-energy CT\, PET-CT\, MRI)\, including the integration of proton and MR-Linac therapy.\nIceland 2026: Nordic research protocols\, including the design of clinical trials for collaborative Nordic implementation and shared patient recruitment.
URL:https://oncodailynews.com/event/200355
ATTACH;FMTTYPE=image/jpeg:https://oncodailynews.com/pub/uploads/2024/11/IMG_7006.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20241107T080000
DTEND;TZID=Europe/Helsinki:20241110T170000
DTSTAMP:20260602T164752
CREATED:20241029T192326Z
LAST-MODIFIED:20250608T081133Z
UID:10000064-1730966400-1731258000@oncodailynews.com
SUMMARY:16th European Multidisciplinary Congress on Urological Cancers EMUC 2024
DESCRIPTION:16th European Multidisciplinary Congress on Urological Cancers EMUC 2024 will take place in Lisbon\, Portugal\, from 7 to 10 November 2024. \nTop experts in medical oncology\, pathology\, radiation oncology\, radiology\, nuclear medicine\, and urology gathered at the EMUC24 congress from 7 to 10 November 2024 to share insights on best practices\, major trial developments\, and breakthroughs. \nThe scientific programme featured in-depth lectures\, practical hands-on courses\, and dynamic multidisciplinary case discussions. EMUC24 highlighted cutting-edge therapies\, current practices\, controversies\, and emerging technologies in GU cancer treatment. \nThis multidisciplinary approach was achieved through collaboration with the European Society for Medical Oncology (ESMO)\, the European Society for Radiotherapy and Oncology (ESTRO)\, and the European Association of Urology (EAU)\, alongside contributions from the Kidney Cancer Association (KCA) on recent kidney cancer advancements.
URL:https://oncodailynews.com/event/174661
LOCATION:Lisbon Congress Centre\, Praça das Indústrias 1\, Lisbon\, 1300-307\, Portugal
ATTACH;FMTTYPE=image/jpeg:https://oncodailynews.com/pub/uploads/2024/10/Esmou.jpg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
END:VCALENDAR